AzTrials
AzTrials

HealthyNCT05905029

Establishment of Biomechanical- and AI- Based Rehabilitation Strategies for Pain Inducing Lifestyles

An observational study of Healthy and Degenerative Disease, run by Bundang CHA Hospital at 2 sites in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To develop biomechanical indicators for pain-inducing lifestyles and apply lifestyle strategies for patients and confirm their effectiveness to be used in artificial intelligence-based digital treatment devices. Read more about this study

Who is it for?
Ages 19 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy, Degenerative Disease
How many people
100 participants
Where
2 sitesSouth Korea
Study dates
4 Aug 2023to 28 Feb 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy subjects and patients who complain pain by degenerative changes in knee or back

Who may be able to join

  • Over 19 years of age
  • Those who scored '0' on the Knee/Back Pain Assessment Scale (VAS)
  • After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
  • Over 19 years of age
  • Those who scored '1' or higher on the Knee Pain Assessment Scale (VAS)
  • After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
Show all 9Show fewer
  • Over 19 years of age
  • Those with a back pain rating scale (VAS) of '1' or higher
  • After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions

Who cannot join

  • Patients who correspond to one or more of the following cannot participate in the study.
  • Those with systemic infectious symptoms at the time of participation in the study
  • Persons with poor systemic conditions such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with cerebrovascular disease
  • Other cases where the researcher judges that participation in this study is not suitable (Patients who are participating in other studies or who have participated in other studies within the past 30 days can also participate in this study.)
  • Subjects who complain pain by degenrative changes in knee
  • Patients who correspond to one or more of the following cannot participate in the study.
Show all 14Show fewer
  • Those with systemic infectious symptoms at the time of participation in the study
  • Persons with poor systemic conditions such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with cerebrovascular disease
  • Other cases where the researcher judges that participation in this study is not suitable (Patients who are participating in other studies or who have participated in other studies within the past 30 days can also participate in this study.)
  • Subjects who complain pain by degenrative changes in back
  • Patients who correspond to one or more of the following cannot participate in the study.
  • Those with systemic infectious symptoms at the time of participation in the study
  • Persons with poor systemic conditions such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with cerebrovascular disease
  • Other cases where the researcher judges that participation in this study is not suitable (Patients who are participating in other studies or who have participated in other studies within the past 30 days can also participate in this study.)

Trial locations and contacts

2 sites in 1 country.

Hyun Jung Oh, Bachelor contact

+82 031 780 6003

a210525@chamc.co.kr

South Korea2 sites, 2 recruiting
  • Department of Rehabilitation Medicine, CHA Bundang Medical Center

    Seongnam, 13496

    MinYoung Kim, MD,PhD

    Recruiting
  • Department of Rehabilitation Medicine, CHA Bundang Medical Center

    Seongnam, 13496

    Hyun Jung Oh, Bachelor, +82 031 780 6003 ext. 6003, a210525@chamc.co.kr

    Not yet recruiting

Other trials in South Korea

About this study

Official title: Establishment of Biomechanical-based Rehabilitation Strategies for Pain-inducing Lifestyles in Degenerative Knee/Back Patients and for Artificial Intelligence-based Rehabilitation System

To develop biomechanical indicators for pain-inducing lifestyles and apply lifestyle strategies for patients and confirm their effectiveness to be used in artificial intelligence-based digital treatment devices.

Read the detailed description

To develop biomechanical indicators for pain-inducing lifestyles and apply lifestyle strategies for patients and confirm their effectiveness to be used in artificial intelligence-based digital treatment devices for patients who complain degenerative knee and back pain.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motion analysis

    Motion capture analysis for kinetic and kinematic data

    Measured: 1 day after screening assessment

Secondary outcomes (2)
  1. Ground reaction force

    GRF measurement for ground reaction force in newtone

    Measured: 1 day after screening assessment

  2. EMG measurement

    Electromyography in maximum voluntary contraction

    Measured: 1 day after screening assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2023
  2. Study start4 Aug 2023
  3. Primary completion28 Feb 2025 (estimated)
  4. Study completion28 Feb 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05905029
Sponsor's protocol ID
2022-11-015
Status last verified
Nov 2023
First submitted
29 May 2023
Last updated
18 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy and Degenerative Disease, run by Bundang CHA Hospital at 2 sites in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hyun Jung Oh, Bachelor (+82 031 780 6003, a210525@chamc.co.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motion analysis (time frame: 1 day after screening assessment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT05905029 | AzTrials